These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 10182885
1. The impact of reimbursement changes for intracoronary stents on providers and Medicare. Vaitkus PT. Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885 [Abstract] [Full Text] [Related]
2. Economic impact on physicians and hospitals of proposed changes in Medicare reimbursement for coronary interventions. Vaitkus PT. Am Heart J; 1999 Feb; 137(2):258-63. PubMed ID: 9924159 [Abstract] [Full Text] [Related]
3. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease. Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A. J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030 [Abstract] [Full Text] [Related]
4. Economic impact of angioplasty salvage techniques, with an emphasis on coronary stents: a method incorporating costs, revenues, clinical effectiveness and payer mix. Vaitkus PT, Witmer WT, Brandenburg RG, Wells SK, Zehnacker JB. J Am Coll Cardiol; 1997 Oct; 30(4):894-900. PubMed ID: 9316515 [Abstract] [Full Text] [Related]
5. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience. Reynolds MR, Neil N, Ho KK, Berezin R, Cosgrove RS, Lager RA, Sirois C, Johnson RG, Cohen DJ. Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853 [Abstract] [Full Text] [Related]
6. Economic impact of drug-eluting stents on hospital systems: a disease-state model. Kong DF, Eisenstein EL, Sketch MH, Zidar JP, Ryan TJ, Harrington RA, Newman MF, Smith PK, Mark DB, Califf RM. Am Heart J; 2004 Mar; 147(3):449-56. PubMed ID: 14999193 [Abstract] [Full Text] [Related]
7. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Chen JC, Kaul P, Levy JH, Haverich A, Menasché P, Smith PK, Carrier M, Verrier ED, Van de Werf F, Burge R, Finnegan P, Mark DB, Shernan SK, PRIMO-CABG Investigators. Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091 [Abstract] [Full Text] [Related]
11. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Cohen DJ, Bakhai A, Shi C, Githiora L, Lavelle T, Berezin RH, Leon MB, Moses JW, Carrozza JP, Zidar JP, Kuntz RE, SIRIUS Investigators. Circulation; 2004 Aug 03; 110(5):508-14. PubMed ID: 15262844 [Abstract] [Full Text] [Related]
13. Medicare's fee schedule for hospital outpatient care. Grimaldi PL. J Health Care Finance; 2002 Aug 03; 28(3):14-31. PubMed ID: 12079149 [Abstract] [Full Text] [Related]
14. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Smith PK, Datta SK, Muhlbaier LH, Samsa G, Nadel A, Lipscomb J. Ann Thorac Surg; 2004 Feb 03; 77(2):635-42; discussion 642-3. PubMed ID: 14759451 [Abstract] [Full Text] [Related]